These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32362156)

  • 21. Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.
    Streiff M; Milentijevic D; McCrae KR; Laliberté F; Lejeune D; Lefebvre P; Schein J; Khorana AA
    J Med Econ; 2019 Nov; 22(11):1134-1140. PubMed ID: 31106638
    [No Abstract]   [Full Text] [Related]  

  • 22. Burden of Crohn's disease in the United States: long-term healthcare and work-loss related costs.
    Manceur AM; Ding Z; Muser E; Obando C; Voelker J; Pilon D; Kinkead F; Lafeuille MH; Lefebvre P
    J Med Econ; 2020 Oct; 23(10):1092-1101. PubMed ID: 32609019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Healthcare resource utilization and costs by age and joint location among osteoarthritis patients in a privately insured population.
    Wang SX; Ganguli AX; Bodhani A; Medema JK; Reichmann WM; Macaulay D
    J Med Econ; 2017 Dec; 20(12):1299-1306. PubMed ID: 28880733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States.
    Zhou Z; Fan Y; Tang W; Liu X; Thomason D; Zhou ZY; Macaulay D; Fischer A
    J Rheumatol; 2019 Aug; 46(8):920-927. PubMed ID: 30770505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder.
    Seetasith A; Greene M; Hartry A; Burudpakdee C
    J Med Econ; 2018 Sep; 21(9):888-901. PubMed ID: 29862860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.
    Pilon D; Joshi K; Sheehan JJ; Zichlin ML; Zuckerman P; Lefebvre P; Greenberg PE
    PLoS One; 2019; 14(10):e0223255. PubMed ID: 31600244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initiating immunoglobulin replacement therapy helps reduce severe infections and shifts healthcare resource utilization to outpatient services among US patients with inborn errors of immunity.
    Riaz F; Umashankar K; Marchlewicz EH; Zhang K; Khandelwal N; Sanchirico M
    J Med Econ; 2024; 27(1):849-857. PubMed ID: 38885115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding healthcare burden and treatment patterns among young adults with schizophrenia.
    Huang A; Amos TB; Joshi K; Wang L; Nash A
    J Med Econ; 2018 Oct; 21(10):1026-1035. PubMed ID: 30001651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.
    To TM; Ta JT; Patel AM; Arndorfer S; Abbass IM; Gandhy R
    J Med Econ; 2023; 26(1):862-870. PubMed ID: 37350423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The economic burden of psoriasis with high comorbidity among privately insured patients in the United States.
    Pilon D; Teeple A; Zhdanava M; Ladouceur M; Ching Cheung H; Muser E; Lefebvre P
    J Med Econ; 2019 Feb; 22(2):196-203. PubMed ID: 30523738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis.
    Li N; Hao Y; Koo V; Fang A; Peeples M; Kageleiry A; Wu EQ; Guérin A
    J Med Econ; 2016; 19(4):414-23. PubMed ID: 27032967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care resource utilization and burden of disease in a U.S. Medicare population with a principal diagnosis of osteoarthritis of the knee.
    Chen F; Su W; Bedenbaugh AV; Oruc A
    J Med Econ; 2020 Oct; 23(10):1151-1158. PubMed ID: 32715848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden of osteoporotic fractures in US managed care enrollees.
    Williams SA; Chastek B; Sundquist K; Barrera-Sierra S; Leader D; Weiss RJ; Wang Y; Curtis JR
    Am J Manag Care; 2020 May; 26(5):e142-e149. PubMed ID: 32436682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of venous leg ulcers in the United States.
    Rice JB; Desai U; Cummings AK; Birnbaum HG; Skornicki M; Parsons N
    J Med Econ; 2014 May; 17(5):347-56. PubMed ID: 24625244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database.
    Zhao Z; Zhu Y; Fang Y; Ye W; McCollam P
    J Med Econ; 2015; 18(9):655-65. PubMed ID: 25891183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of the healthcare costs of metastatic breast cancer: A retrospective matched cohort study.
    Chen HM; Chen JH; Chiang SC; Lin YC; Ko Y
    Medicine (Baltimore); 2021 Oct; 100(43):e27567. PubMed ID: 34713830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis.
    Weycker D; Hanau A; Hatfield M; Wu H; Sharma A; Bensink ME; Chandler D; Grossman A; Tarantino M
    J Med Econ; 2020 Feb; 23(2):184-192. PubMed ID: 31547724
    [No Abstract]   [Full Text] [Related]  

  • 40. Real-world annualized healthcare utilization and expenditures among insured US patients with acute intermittent porphyria (AIP) treated with hemin.
    Blaylock B; Epstein J; Stickler P
    J Med Econ; 2020 Jun; 23(6):537-545. PubMed ID: 31999204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.